Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SSBP3 pseudogene 3 (SSBP3P3) is a non-coding pseudogene related to the single stranded DNA binding protein 3 (SSBP3) gene. As a pseudogene, it is not expected to encode a functional protein or have direct biological activity, nor is it characterized as a therapeutic target. Pseudogenes may arise from gene duplication or retrotransposition events and can sometimes have regulatory roles at the RNA level, but there is currently no evidence that SSBP3P3 is actively involved in cellular function or disease[5]. The functional SSBP3 gene is a protein-coding gene involved in transcriptional regulation through binding single-stranded DNA and acting as a transcription coactivator[1][2][3], but SSBP3P3 is distinct from this functional gene as it is annotated as a pseudogene[5]. No known biological functions, drug interactions, or disease associations have been reported for SSBP3P3[5]. SSBP3P3 should not be confused with SSBP3 (single stranded DNA binding protein 3), which is an active gene with described molecular functions and developmental roles[1][2][3]. This entry is valid for a pseudogene but is not a molecular drug target or disease gene as defined in most biomedical databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SSBP3 pseudogene 3 (SSBP3P3).